CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 195 filers reported holding CLOVIS ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $336,000 | -25.2% | 166,500 | +0.4% | 0.00% | – |
| Q4 2021 | $449,000 | -72.5% | 165,800 | -54.7% | 0.00% | -100.0% |
| Q3 2021 | $1,631,000 | +28.4% | 365,800 | +67.1% | 0.00% | 0.0% |
| Q2 2021 | $1,270,000 | +114.5% | 218,900 | +159.7% | 0.00% | – |
| Q1 2021 | $592,000 | +46.2% | 84,300 | 0.0% | 0.00% | – |
| Q4 2020 | $405,000 | -26.2% | 84,300 | -10.4% | 0.00% | – |
| Q3 2020 | $549,000 | -37.3% | 94,100 | -27.4% | 0.00% | -100.0% |
| Q2 2020 | $875,000 | +67.9% | 129,700 | +58.4% | 0.00% | – |
| Q1 2020 | $521,000 | -29.6% | 81,900 | +15.4% | 0.00% | – |
| Q4 2019 | $740,000 | +126.3% | 71,000 | -14.6% | 0.00% | – |
| Q3 2019 | $327,000 | -68.2% | 83,140 | +20.4% | 0.00% | -100.0% |
| Q2 2019 | $1,027,000 | -78.5% | 69,040 | -64.1% | 0.00% | -66.7% |
| Q1 2019 | $4,774,000 | -36.6% | 192,340 | -54.1% | 0.00% | -50.0% |
| Q4 2018 | $7,526,000 | -81.9% | 419,040 | -70.4% | 0.01% | -77.8% |
| Q3 2018 | $41,548,000 | -4.1% | 1,414,652 | +48.4% | 0.03% | -10.0% |
| Q2 2018 | $43,334,000 | -30.3% | 953,023 | -19.1% | 0.03% | -33.3% |
| Q1 2018 | $62,197,000 | -8.8% | 1,177,977 | +17.5% | 0.04% | -8.2% |
| Q4 2017 | $68,197,000 | -13.9% | 1,002,897 | +4.3% | 0.05% | -16.9% |
| Q3 2017 | $79,250,000 | -11.7% | 961,777 | +0.3% | 0.06% | -14.5% |
| Q2 2017 | $89,765,000 | +87.0% | 958,721 | +27.1% | 0.07% | +81.6% |
| Q1 2017 | $48,015,000 | +2247.9% | 754,122 | +1538.0% | 0.04% | +1800.0% |
| Q4 2016 | $2,045,000 | +23.2% | 46,040 | 0.0% | 0.00% | +100.0% |
| Q3 2016 | $1,660,000 | +161.0% | 46,040 | -0.6% | 0.00% | 0.0% |
| Q2 2016 | $636,000 | -28.5% | 46,340 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $890,000 | -45.1% | 46,340 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $1,622,000 | -61.9% | 46,340 | 0.0% | 0.00% | -75.0% |
| Q3 2015 | $4,261,000 | +5.0% | 46,340 | +0.3% | 0.00% | +33.3% |
| Q2 2015 | $4,060,000 | +18.4% | 46,200 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $3,429,000 | +31.1% | 46,200 | -1.1% | 0.00% | +50.0% |
| Q4 2014 | $2,615,000 | +28.4% | 46,700 | +4.0% | 0.00% | 0.0% |
| Q3 2014 | $2,037,000 | +11.3% | 44,900 | +1.6% | 0.00% | 0.0% |
| Q2 2014 | $1,830,000 | -27.0% | 44,200 | +22.1% | 0.00% | 0.0% |
| Q1 2014 | $2,508,000 | +21.3% | 36,200 | +5.5% | 0.00% | 0.0% |
| Q4 2013 | $2,067,000 | -92.7% | 34,300 | -92.6% | 0.00% | -92.9% |
| Q3 2013 | $28,244,000 | +21.0% | 464,698 | +33.4% | 0.03% | +12.0% |
| Q2 2013 | $23,336,000 | – | 348,402 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 2,279,781 | $138,611,000 | 5.49% |
| Redmile Group, LLC | 471,345 | $28,648,000 | 4.32% |
| PFM Health Sciences, LP | 2,026,908 | $123,236,000 | 2.97% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $48,066,000 | 2.85% |
| Partner Investment Management, L.P. | 153,006 | $9,303,000 | 2.48% |
| Consonance Capital Management LP | 141,500 | $8,603,000 | 2.15% |
| QVT Financial LP | 344,960 | $20,974,000 | 1.43% |
| BB BIOTECH AG | 381,886 | $23,219,000 | 1.26% |
| SECTORAL ASSET MANAGEMENT INC | 426,200 | $25,913,000 | 1.25% |
| Perceptive Advisors | 389,402 | $23,676,000 | 0.98% |